HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Author： Fehm Tanja   Müller Volkmar   Aktas Bahriye   Janni Wolfgang   Schneeweiss Andreas   Stickeler Elmar   Lattrich Claus   Löhberg Christian   Solomayer Erich   Rack Brigitte   Riethdorf Sabine   Klein Christoph   Schindlbeck Christian   Brocker Kerstin   Kasimir-Bauer Sabine   Wallwiener Diethelm   Pantel Klaus  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.124, Iss.2, 2010-11, pp. : 403-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer

By Hayashi Naoki  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 96-104

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

By Modi Shanu  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

By Somlo G.   Martel C.   Lau S.   Frankel P.   Ruel C.   Gu L.   Hurria A.   Chung C.   Luu T.   Morgan R.   Leong L.   Koczywas M.   McNamara M.   Russell C.   Kane S.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

By Amadori D.   Frassineti G.L.   de Matteis A.   Mustacchi G.   Santoro A.   Cariello S.   Ferrari M.   Nascimben O.   Nanni O.   Lombardi A.   Scarpi E.   Zoli W.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 209-217

Springer Publishing Company

Access to resources Recommend Favorite